The Piramal Pharma Solutions facility in Aurora Canada offers development, clinical and commercial GMP manufacturing of Active Pharmaceutical Ingredients (APIs) for complex pharmaceutical NCEs. It is a US FDA, Health Canada and PMDA inspected site.
The Piramal Pharma Solutions facility in Aurora Canada offers development, clinical and commercial GMP manufacturing of Active Pharmaceutical Ingredients (APIs) for complex pharmaceutical NCEs. It is a US FDA, Health Canada and PMDA inspected site.
Winning approval for a new molecular entity is just a staging post on the journey of a drug. To maximize the benefits of a therapy, drugmakers need to continue trying to improve the product life cycle and reach more patients after winning first approval.
Operational Excellence (OE) is a key element of organizational leadership and intelligence. For a CDMO operating in the pharmaceutical industry, OE focuses on serving patients and customers efficiently in aspects of safety, quality, delivery and cost.
For more product information visit Piramal Pharma Solutions.